Combination preparation containing heterocyclidene acetamide derivative
AssigneesSenju Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd.
InventorYuki YAMASHITA
Life of this patent
Estimating the term…
Loading patent…
AssigneesSenju Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd.
InventorYuki YAMASHITA
Estimating the term…
The present disclosure provides a suspension-type ophthalmic solution having excellent re-dispersibility. More specifically, the present disclosure provides a water-based suspension preparation containing a first component and a second component, in which the first component is (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl) acetamide or a pharmaceutically acceptable salt or solvate thereof, and the second component comprises at least one component selected from the group consisting of diquafosol, ciclosporin, hyaluronic acid, loteprednol etabonate, bromfenac, fluorometholone and pharmaceutically acceptable salts or solvates thereof.
An aqueous suspension liquid formulation comprising:
Dependencies are inferred from the claim text.